These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1893642

  • 1. The pharmacokinetics of benazepril relative to other ACE inhibitors.
    Gengo FM, Brady E.
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.
    Kaiser G, Ackermann R, Dieterle W, Durnin CJ, McEwen J, Ghose K, Richens A, Holmes IB.
    Eur J Clin Pharmacol; 1990 Aug; 38(4):379-85. PubMed ID: 2344861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations.
    Kaiser G, Ackermann R, Sioufi A.
    Am Heart J; 1989 Mar; 117(3):746-51. PubMed ID: 2919553
    [Abstract] [Full Text] [Related]

  • 10. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment.
    Kitagawa H, Eguchi T, Kitoh K, Ohba Y, Kondo M, Nakano M, Sasaki Y.
    J Vet Med Sci; 2000 Feb; 62(2):179-85. PubMed ID: 10720188
    [Abstract] [Full Text] [Related]

  • 11. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F, Kaiser G, Ackermann R, Faigle JW, Wagner J, Barner A, Lasseter KC.
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [Abstract] [Full Text] [Related]

  • 12. Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach.
    Toutain PL, Lefebvre HP, King JN.
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1087-93. PubMed ID: 10688627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA, Goa KL.
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [Abstract] [Full Text] [Related]

  • 15. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.
    King JN, Strehlau G, Wernsing J, Brown SA.
    J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration.
    Kaiser G, Ackermann R, Brechbühler S, Dieterle W.
    Biopharm Drug Dispos; 1989 Oct; 10(4):365-76. PubMed ID: 2758102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.